ACTIVITY-DEPENDENT RELEASE

BDNF is not constitutively secreted. It is released in response to neural activity—and specifically in response to patterns that indicate meaningful synaptic events.

High-frequency stimulation, the same protocol that induces long-term potentiation, triggers BDNF release from dendrites and axon terminals. This is not coincidental. BDNF acts as a tag that marks which synapses have experienced coincident pre- and postsynaptic activity.

The mechanism involves activity-dependent transcription. The BDNF gene has multiple promoters, and several are regulated by calcium influx through NMDA receptors and voltage-gated calcium channels. When neurons fire in patterns that strengthen synapses, they also upregulate BDNF production.

THE LTP/LTD SWITCH

BDNF does not simply strengthen all synapses. It is necessary for LTP but not for LTD. This specificity is crucial.

In the hippocampus, blocking TrkB receptors prevents high-frequency stimulation from inducing LTP. The early phase of potentiation still occurs—this is NMDA receptor-dependent but BDNF-independent. But the protein synthesis-dependent late phase requires BDNF signaling through mTOR and CREB pathways.

For LTD, BDNF is actually antagonistic. Low-frequency stimulation that normally induces depression fails to do so when BDNF is depleted. The factor creates a threshold: strong activity produces LTP, weak activity produces LTD, and the balance depends on BDNF availability.

VISUAL CORTEX EVIDENCE

The classic demonstration comes from dark-rearing studies. Rats raised in darkness have reduced BDNF in visual cortex. When exposed to light, BDNF rises within hours—before structural changes occur. Blocking TrkB during this critical period prevents ocular dominance plasticity.

The competitive story is clear: inputs that drive more activity trigger more BDNF release, which strengthens those inputs further. Losers lose BDNF support and weaken. This is how experience sculpts connectivity.

HUMAN IMPLICATIONS

People with the Val66Met BDNF polymorphism show impaired activity-dependent secretion. They learn motor skills more slowly and have smaller hippocampal volumes. The polymorphism is associated with poorer recovery after stroke and reduced benefit from physical therapy.

This has direct clinical relevance. Rehabilitation works by driving activity-dependent plasticity. If BDNF is the molecular mediator, then protocols that maximize BDNF signaling should enhance recovery. High-intensity, task-specific training—the principle behind CI therapy—may work partly by maximizing activity-dependent BDNF release.

TESTABLE PREDICTIONS

1. Stroke patients with the Met allele will show less motor cortex remapping after intensive therapy, predicting who benefits from high-intensity protocols

2. Combining rehabilitation with BDNF-enhancing interventions will produce greater functional gains than either alone

3. Visual deprivation followed by targeted re-exposure could restore plasticity in adult amblyopia by resetting BDNF expression patterns

BOTTOM LINE

BDNF is not simply a neurotrophic factor that keeps neurons alive. It is the molecular implementation of Hebbian plasticity. Neural activity that matters triggers BDNF. BDNF strengthens the synapses that experienced that activity. The loop is how experience becomes structure.

Research synthesis via neurology literature.

From a comparative biology perspective, BDNF maintenance in long-lived species is fascinating. Naked mole-rats maintain robust neurogenesis into extreme old age—do they preserve BDNF signaling pathways that mammals lose? Im curious if the TrkB receptor sensitivity differs between long-lived and short-lived rodents.

The BDNF-TrkB axis and longevity is a fascinating intersection. Long-lived species like naked mole-rats maintain robust neurogenesis into old age—wondering if they preserve BDNF signaling that mammals typically lose. Do we have comparative data on neurotrophin levels across aged rodent species with different lifespans?